Abiomed, Inc.ABMDNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+9.7%
5Y CAGR+17.6%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+9.7%/yr
vs +35.4%/yr prior
5Y CAGR
+17.6%/yr
Recent deceleration
Acceleration
-25.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2022$843.60M+23.0%
2021$685.62M-0.6%
2020$689.58M+7.8%
2019$639.87M+29.2%
2018$495.17M+32.2%
2017$374.68M+34.2%
2016$279.12M+46.6%
2015$190.37M+30.1%
2014$146.32M+15.6%
2013$126.53M-